Navigation Links
Research at the cutting edge of knowledge

The Brazilian funding agency for scientific and technological research So Paulo Research Foundation, FAPESP, based in the state of So Paulo, announced an investment estimated in US$ 680 million to support 17 Research, Innovation and Dissemination Centers (RIDCs) for a period of up to eleven years, subject to continuation reviews on years 2, 4 and 7.

Funding for the 17 RIDCs will come from FAPESP and the host institutions (through funding faculty, technicians, support personnel, and infrastructure). Host institutions will participate in a portion of US$ 310 million of this amount for the payment of salaries and additional funding will be obtained by each center from industry and government organizations.

Each selected RIDC is expected to establish a hub of excellent research in its focus area. In addition, each RIDC must actively seek out and develop opportunities to have its research results contribute to commercially and/or socially relevant high-impact applications, as well as contributing to education and dissemination of knowledge.

The 17 RIDCs bring together 535 scientists from the State of So Paulo and 69 scientists from other countries. The research topics covered by the centers include the following: food and nutrition; glasses and glass-ceramics; functional materials; neuroscience and neurotechnology; inflammatory diseases; biodiversity and drug discovery; toxins, immune-response and cell signaling; neuromathematics; mathematical sciences applied to industry; obesity and associated diseases; cellular therapy; metropolitan studies; human genome and stem-cells; computational engineering; redox processes in biomedicine; violence; and optics, photonics, and atomic and molecular physics.


  • Food Research Center FoRC
  • Center for Research, Teaching, and Innovation in Glass CEPIV
  • Center for Research and Development of Functional Materials CDFM
  • Brazilian Research Institute for Neuroscience and Neurotechnology BRAINN
  • Center for Research on Inflammatory Diseases CRID
  • Center for Research and Innovation in Biodiversity and Drug Discovery CIBFar
  • Center for Research on Toxins, Immune Response and Cell Signaling CeTICS
  • Research, Innovation and Dissemination Center for Neuromathematics NEUROMAT
  • Center for Research in Mathematical Sciences Applied to Industry CeMEAI
  • Obesity and Co-Morbidities Research Center OCRC
  • Center for Research in Cell Therapy CTC
  • Center for Metropolitan Studies CEM
  • Human Genome and Stem-Cell Research Center HUG-CELL
  • Center for Computational Science and Engineering CECC
  • Center for Research on Redox Processes in Biomedicine REDOXOME
  • Center for the Study of Violence NEV-USP
  • Optics and Photonics Research Center CEPOF


Contact: Fernando Cunha
Fundao de Amparo Pesquisa do Estado de So Paulo

Related medicine news :

1. Fertility Clinics in Australia Industry Market Research Report Now Available from IBISWorld
2. Iowa VP for Research addresses next-generation supercomputers at congressional hearing
3. JPIDS: Releases consensus statement on research definitions for drug-resistant TB in children
4. Adeptia Featured in Recent 451 Research Impact Report
5. NYUs Movshon receives Lashley Award for his research on the neuroscience of vision
6. New multi-million dollar research center aims to solve the mystery of premature birth
7. Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research
8. North America Leads Automated External Defibrillator Market (AED), Says New Research Report at
9. Packaging and Labelling Services in Canada Industry Market Research Report Now Available from IBISWorld
10. Environmental Design Research Conference to Feature AIA/CES, LA CES, and IDCEC Continuing Education Credits
11. Leading researchers report on the elusive search for biomarkers in Huntingtons disease
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... Lakeview Health, ... country to celebrate their sobriety and show through pictures what a positive difference ... photos this Thanksgiving with the hashtag #FacesOfGratitude on their Facebook, Twitter, and Instagram ...
(Date:11/25/2015)... ... November 25, 2015 , ... On November 23rd 2015 Cozy Products, ... heating products business. Cozy Products explains what this means for business moving forward. , ... the Cozy Products business model: to sell personal heaters that reduce energy consumption, are ...
(Date:11/25/2015)... Livonia, MI (PRWEB) , ... November 25, 2015 , ... ... at Presence Resurrection Medical Center (RMC) in Chicago, IL, UV Angel is evaluating the ... the medical and surgical intensive care units (totaling 30 beds) from May 2014 through ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... found that regular bras were incredibly uncomfortable," said an inventor from Bronx, N.Y. ... , She developed the patent-pending RECOVERY BRA for added comfort and support. The ...
(Date:11/25/2015)... ... , ... Since its launch in 2012, the Regenestem brand ... therapies to patients with chronic degenerative medical conditions. Now, the U.S. Patent and ... , Organizations are required to hold a registered trademark in order to make ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... 24, 2015  Thanks to a donor with a ... Medical Center,s Sister Diane Grassilli Center for Women,s Health ... San Francisco . ... forward with a gift of $617,320 that allowed the ... with Tomosynthesis and Whole Breast Ultrasound. Tomosynthesis, three-dimensional (3-D) ...
(Date:11/24/2015)... , Nov. 24, 2015  Array BioPharma Inc. ... Chief Executive Officer, Ron Squarer , will ... in New York.  The public is welcome to ... the Array BioPharma website.Event:Piper Jaffray Annual Healthcare ConferencePresenter:  ... December 2, 2015Time:1:30 p.m. Eastern Time Webcast: ...
(Date:11/24/2015)... Nov. 24, 2015 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" ... announced today that the first patient has been enrolled ... a treatment for metastatic castration-resistant prostate cancer ("mCRPC"). ... --> the United States ... Phase 1/2 clinical trial, ESSA intends to demonstrate the ...
Breaking Medicine Technology: